Inhibition of 11 beta-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

DSpace Repository

Inhibition of 11 beta-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

Author: Stefan, Norbert; Ramsauer, Markus; Jordan, Paul; Nowotny, Bettina; Kantartzis, Konstantinos; Machann, Juergen; Hwang, Jong-Hee; Nowotny, Peter; Kahl, Sabine; Harreiter, Juergen; Hornemann, Silke; Sanyal, Arun J.; Stewart, Paul M.; Pfeiffer, Andreas F.; Kautzky-Willer, Alexandra; Roden, Michael; Haering, Hans-Ulrich; Fuerst-Recktenwald, Sabine
Tübinger Autor(en):
Stefan, Norbert
Kantartzis, Konstantinos
Machann, Jürgen
Häring, Hans-Ulrich
Published in: Lancet Diabetes & Endocrinology (2014), Bd. 2, H. 5, S. 406-416
Verlagsangabe: Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S2213-8587(13)70170-0
ISSN: 2213-8587
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)